Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Mayo Clinic Partner to Study Genetic Disorders

NEW YORK (GenomeWeb) – Illumina and the Mayo Clinic said today that they have formed a partnership to study and interpret genetic variants involved in disease.

Under the terms of the deal, Mayo will test Illumina's BaseSpace Clarity LIMS in specific laboratories to determine how well it tracks and integrates workflows in the lab. Mayo will also deploy Illumina's cloud-based genomics computing environment, BaseSpace Sequence Hub, for data analysis and management, and its cloud-based interpretation and reporting platform BaseSpace Variant Interpreter. Mayo will use these tools to annotate and interpret genetic variants to study their potential role in the development and progression of various diseases.

Further terms of the collaboration were not disclosed.

"Through this relationship, we will be able to generate large volumes of genomic information, interrogate the data, and then compare it to what's known about those variants and those genetic aberrations in real time, saving our geneticists time," William Morice, chair of Mayo's department of laboratory medicine and pathology and president of Mayo Medical Laboratories, said in a statement. "We are pleased to work with Illumina and to leverage each other's expertise in genetic sequencing and analysis."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.